Fenna W. B. Craenmehr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fenna W. B. Craenmehr has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Patricia Y. W. Dankers
Institute for Complex Molecular Systems, Eindhoven University of Technology Eindhoven The Netherlands
2 shared publications - Auke A. Koops
Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, Eindhoven 5600 MB, The Netherlands
1 shared publication - Bente A. Somsen
Department of Biomedical Engineering and Institute for Complex Molecular Systems Laboratory of Chemical Biology Eindhoven University of Technology P.O. Box 513, MB Eindhoven 5600 Eindhoven The Netherlands
1 shared publication - Christian Ottmann
Eindhoven University of Technology
1 shared publication E. W. Meijer
Institute for Complex Molecular Systems Eindhoven University of Technology Eindhoven 5600 MB The Netherlands
1 shared publication- Emira J. Visser
Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology
1 shared publication
Latest Publications
- Open Access
- 4 September 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (8) , e02079
Controlling Intestinal Organoid Polarity using Synthetic Dynamic Hydrogels Decorated with Laminin‐Derived IKVAV Peptides
Intestinal organoids are three‐dimensional cellular structures that are cultured in laminin‐rich Matrigel, yielding organoids with correct, basal‐out polarity. Removal of Matrigel results in organoids with reversed, apical‐out polarity, demonstrating its vital role. However, Matrigel's composition is ill‐defined, and its pathogenic origin poses challenges in reproducibility. Therefore, we here introduce a fully synthetic dynamic hydrogel that presents the IKVAV peptide as a laminin‐mimic for guiding intestinal organoid polarity in a minimalistic, controlled manner. The ureido‐pyrimidinone moiety is used to form supramolecular hydrogels that have orthogonal control over properties, like stiffness, ligand type and concentration. It is found that the IKVAV peptide combined with integrin activating antibody TS2/16 controls intestinal organoid polarity. Increasing hydrogel dynamics (stress‐relaxing half‐life time of ≈1000 to 30 s) further supports the growth of intestinal organoids with correct polarity, while a bulk level of stiffness ( G ’ ≈0.7 kPa) is crucial to offer mechanical support. Through manipulation of integrins, it is revealed that the IKVAV‐organoid interaction is integrin β1‐mediated. Our findings demonstrate the essential role of the IKVAV motif in guiding intestinal organoid polarity in synthetic dynamic hydrogels – paving the way for the future design of synthetic systems to culture complex living tissue.
- 4 September 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (8) , e02079
Open AccessControlling Intestinal Organoid Polarity using Synthetic Dynamic Hydrogels Decorated with Laminin‐Derived IKVAV Peptides
Intestinal organoids are three‐dimensional cellular structures that are cultured in laminin‐rich Matrigel, yielding organoids with correct, basal‐out polarity. Removal of Matrigel results in organoids with reversed, apical‐out polarity, demonstrating its vital role. However, Matrigel's composition is ill‐defined, and its pathogenic origin poses challenges in reproducibility. Therefore, we here introduce a fully synthetic dynamic hydrogel that presents the IKVAV peptide as a laminin‐mimic for guiding intestinal organoid polarity in a minimalistic, controlled manner. The ureido‐pyrimidinone moiety is used to form supramolecular hydrogels that have orthogonal control over properties, like stiffness, ligand type and concentration. It is found that the IKVAV peptide combined with integrin activating antibody TS2/16 controls intestinal organoid polarity. Increasing hydrogel dynamics (stress‐relaxing half‐life time of ≈1000 to 30 s) further supports the growth of intestinal organoids with correct polarity, while a bulk level of stiffness ( G ’ ≈0.7 kPa) is crucial to offer mechanical support. Through manipulation of integrins, it is revealed that the IKVAV‐organoid interaction is integrin β1‐mediated. Our findings demonstrate the essential role of the IKVAV motif in guiding intestinal organoid polarity in synthetic dynamic hydrogels – paving the way for the future design of synthetic systems to culture complex living tissue.
- Open Access
- 29 May 2025
- Published by Wiley in Journal of Polymer Science
- Vol. 63 (14) , 2934-2943
Controlling Drug Release From Supramolecular Polymer Surfaces by a Click‐To‐Release Reaction
Here, we introduce the combination of reactive supramolecular additives with a covalent click‐to‐release reaction. Hereto, a reactive supramolecular trans‐cyclooctene (TCO) additive is synthesized to trigger the release of a cytotoxic drug from a ureido‐pyrimidinone (UPy) based supramolecular material by soluble tetrazine (Tz) administration. Therefore, two reactive additives are designed. First, to monitor the reaction, a fluorescent UPy‐TCO‐Cy5 additive is synthesized and incorporated in a supramolecular polymer material. Reaction with Tz shows an increase in fluorescent signal in the supernatant, indicating successful release. Next, a cytotoxic UPy‐TCO‐MMC additive is synthesized and incorporated in a supramolecular polymer material where reaction with Tz results in the cell death of breast cancer cells. This study presents a new strategy for on‐demand localized drug delivery to cells from a supramolecular surface.
- 29 May 2025
- Published by Wiley in Journal of Polymer Science
- Vol. 63 (14) , 2934-2943
Open AccessControlling Drug Release From Supramolecular Polymer Surfaces by a Click‐To‐Release Reaction
Here, we introduce the combination of reactive supramolecular additives with a covalent click‐to‐release reaction. Hereto, a reactive supramolecular trans‐cyclooctene (TCO) additive is synthesized to trigger the release of a cytotoxic drug from a ureido‐pyrimidinone (UPy) based supramolecular material by soluble tetrazine (Tz) administration. Therefore, two reactive additives are designed. First, to monitor the reaction, a fluorescent UPy‐TCO‐Cy5 additive is synthesized and incorporated in a supramolecular polymer material. Reaction with Tz shows an increase in fluorescent signal in the supernatant, indicating successful release. Next, a cytotoxic UPy‐TCO‐MMC additive is synthesized and incorporated in a supramolecular polymer material where reaction with Tz results in the cell death of breast cancer cells. This study presents a new strategy for on‐demand localized drug delivery to cells from a supramolecular surface.
- Open Access
- 25 October 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (44) , 13122-13131
Functional mapping of the 14-3-3 hub protein as a guide to design 14-3-3 molecular glues
Molecular glues represent an evolution in drug discovery, however, targeted stabilization of protein complexes remains challenging, owing to a paucity of drug design rules. The functional mapping of hotspots has been critical to protein–protein interaction (PPI) inhibitor research, however, the orthogonal approach to stabilize PPIs has not exploited this information. Utilizing the hub protein 14-3-3 as a case study we demonstrate that functional mapping of hotspots provides a triage map for 14-3-3 molecular glue development. Truncation and mutation studies allowed deconvoluting the energetic contributions of sidechain and backbone interactions of a 14-3-3-binding non-natural peptide. Three central 14-3-3 hotspots were identified and their thermodynamic characteristics profiled. In addition to the phospho-binding pocket; (i) Asn226, (ii) Lys122 and (iii) the hydrophobic patch formed by Leu218, Ile219 and Leu222 were critical for protein complex formation. Exploiting this hotspot information allowed a peptide-based molecular glue that elicits high cooperativity (α = 36) and selectively stabilizes the 14-3-3/ChREBP PPI to be uniquely developed.
- 25 October 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (44) , 13122-13131
Open AccessFunctional mapping of the 14-3-3 hub protein as a guide to design 14-3-3 molecular glues
Molecular glues represent an evolution in drug discovery, however, targeted stabilization of protein complexes remains challenging, owing to a paucity of drug design rules. The functional mapping of hotspots has been critical to protein–protein interaction (PPI) inhibitor research, however, the orthogonal approach to stabilize PPIs has not exploited this information. Utilizing the hub protein 14-3-3 as a case study we demonstrate that functional mapping of hotspots provides a triage map for 14-3-3 molecular glue development. Truncation and mutation studies allowed deconvoluting the energetic contributions of sidechain and backbone interactions of a 14-3-3-binding non-natural peptide. Three central 14-3-3 hotspots were identified and their thermodynamic characteristics profiled. In addition to the phospho-binding pocket; (i) Asn226, (ii) Lys122 and (iii) the hydrophobic patch formed by Leu218, Ile219 and Leu222 were critical for protein complex formation. Exploiting this hotspot information allowed a peptide-based molecular glue that elicits high cooperativity (α = 36) and selectively stabilizes the 14-3-3/ChREBP PPI to be uniquely developed.